Bortezomib Against Refractory Antibody-Mediated Rejection After ABO-Incompatible Living-Donor Liver Transplantation: Dramatic Effect in Acute-Phase? by Tetsuya Tajima, MD, Koichiro Hata, MD, PhD, Hideaki Okajima, MD, PhD, Momoko Nishikori, MD, PhD, Kentaro Yasuchika, MD, PhD, Jiro Kusakabe, MD, Atsushi Yoshizawa, MD, PhD, Ken Fukumitsu, MD, PhD, Takayuki Anazawa, MD, PhD, Hirokazu Tanaka, MD, Seidai Wada, MD, PhD, Junshi Doi, MD, Akifumi Takaori-Kondo, MD, PhD, Shinji Uemoto, MD, PhD

Get full text